Last edition
News about "Telix Pharmaceuticals "
Telix Plans to Add FAP-Targeting Candidates to Theranostic Pipeline
Telix has entered into asset purchase and exclusive worldwide in-licence agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine (diagnostic) radiopharmaceutical candidates.
Telix Pharmaceuticals | 19/11/2024 | By Aishwarya
Telix Announces Acquisition of RLS to Expand its North American Manufacturing Footprint
This acquisition of RLS is aligned with Telix's investment strategy around vertically integrated supply chain, manufacturing, and distribution, further enabling the delivery of future clinical and commercial radiopharmaceutical products.
Telix Pharmaceuticals | 23/09/2024 | By Aishwarya | 107
Telix Completes TLX250-CDx BLA Submission for Kidney Cancer Imaging
Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the United States (US) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET agent.
Telix Pharmaceuticals | 03/06/2024 | By Aishwarya
Telix Pharmaceuticals Completes Acquisition of ARTMS
Telix Pharmaceuticals Ltd. has completed the acquisition of ARTMS Inc.
<br />
Telix Pharmaceuticals | 12/04/2024 | By Aishwarya | 248
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy